Skip to content

Bone research: ISAS participates in the new "DIONE" Collaborative Research Centre

Dortmund, 1st December 2023

What is the connection between our immune system and bone fractures? Why can autoimmune diseases such as rheumatoid arthritis, illnesses such as psoriatic arthritis or chronic inflammatory bowel diseases affect the skeleton? For the first time, scientists will be investigating these questions in the new Collaborative Research Centre (CRC) / Transregio 369 "DIONE". Researchers at Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Technische Universität Dresden, ISAS and the University of Ulm will be looking into inflammation-induced bone degeneration. The German Research Foundation is funding "DIONE – DegeneratIon of bONE induced by inflammation" for an initial period of four years.

It is known that the immune system reacts to inflammation and releases various mediators such as metabolites. The latter have an effect on bone remodelling by influencing the balance between osteoblasts (bone-building cells) and osteoclasts (bone-degrading cells). However, how exactly the intracellular and extracellular regulatory circuits control inflammation and skeletal reactions has not yet been explored. The scientists at DIONE want to change this by incorporating the latest developments and findings on inflammatory diseases from immunology and bone biology into their research project.

This is why researchers at ISAS and FAU will use various microscopy techniques to investigate whether different osteoclast subpopulations have different activation profiles and functions in addition to their different origins. "We want to find out more about the individual regulatory mechanisms of different osteoclast subtypes during different inflammatory processes and their influence on disease-specific bone damage. We would like to use these new findings to identify potential targets for more specific therapies for various skeletal-associated diseases such as rheumatoid arthritis and osteoporosis," says Prof Dr Anika Grüneboom from the ISAS Bioimaging research group. Together with Prof Dr Gerhard Krönke (FAU / Charité - Universitätsmedizin Berlin), she is leading the corresponding "DIONE" sub-project.

Prof Dr Anika Grüneboom

© ISAS / Hannes Woidich

Share

Further articles

8th September 2025

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.
8th September 2025

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.

23rd July 2025

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.
8th July 2025

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.
25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.